secwatch.observer — SEC 8-K summary
======================================

Issuer:     HUMANIGEN, INC (—)
CIK:        0001293310
Form:       8-K
Filed at:   2023-04-06T23:59:59+00:00
Accession:  0001214659-23-005046
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humanigen receives additional Nasdaq delisting notice for MVLS non-compliance; hearing held April 6
--------------------------------------------------------------------------------

- Nasdaq notified Humanigen on April 5 that it failed to meet minimum $35M MVLS requirement as of April 3.
- Company requested a 180-day extension until Aug 21, 2023 at hearing on April 6; Panel decision expected within 30 days.
- Trading suspension stayed pending hearing process and any extension granted, up to 180 days from Feb 21, 2023.
- Non-compliance also involves bid price below $1.00 and stockholders' equity requirements for Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1293310/000121465923005046/0001214659-23-005046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1293310/000121465923005046/g462338k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-23-005046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer